REG - Tate & Lyle PLC - Share Consolidation Effective Total Voting Rights

Tate & LyleAnnouncement

03/05/2022 08:15

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20220503:nRSC0657Ka&default-theme=true

RNS Number : 0657K  Tate & Lyle PLC  03 May 2022

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, IN, INTO OR
FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE
RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION.

 

FOR IMMEDIATE RELEASE

 

3 May 2022

Tate & Lyle PLC

("Tate & Lyle")

 

Share Consolidation Effective and Total Voting Rights

 

Further to the announcement made by Tate & Lyle on 26 April 2022 that
shareholder approval was granted at the General Meeting for the Special
Dividend and associated Share Consolidation, Tate & Lyle is pleased to
announce that the Share Consolidation has today become effective.

 

Admission of Tate & Lyle's New Ordinary Shares to the premium listing
segment of the Official List of the Financial Conduct Authority and to trading
on the London Stock Exchange's Main Market for listed securities took place at
8.00 a.m. today.

 

The ISIN for the New Ordinary Shares is GB00BP92CJ43.

 

As a result of the Share Consolidation and in accordance with the requirements
of the FCA's Disclosure Guidance and Transparency Rule 5.6.1A, Tate &
Lyle's issued share capital as at 8.00 a.m. on 3 May 2022 consisted of
401,603,808 ordinary shares of 29(1)/(6) pence each and 2,394,000 preference
shares of £1.00 each, which have limited voting rights. Tate & Lyle does
not hold any shares in treasury. Therefore, the total number of shares with
full voting rights in Tate & Lyle as at 8.00 a.m. on 3 May 2022 was
401,603,808.

 

The above figure may be used by shareholders and others with notification
obligations as their denominator for the calculations by which they will
determine if they are required to notify their interest in, or a change to
their interest in, Tate & Lyle under the FCA's Disclosure Guidance and
Transparency Rules.

 

Capitalised terms used but not otherwise defined in this Announcement have the
same meaning given to them in the shareholder circular dated 7 April 2022.

 

For more information contact:

 

For Tate & Lyle PLC

 

Investors and analysts

Christopher Marsh, VP Investor Relations

Tel: Mobile: +44 (0) 7796 192 688

 

Media

Nick Hasell, FTI Consulting

Tel: Mobile: +44 (0) 7825 523 383

 

Information on Tate & Lyle

 

Tate & Lyle is a leading global provider of food and beverage ingredients
and solutions. Supported by our 160-year history of ingredient innovation, we
partner with customers to provide consumers with healthier and tastier choices
when they eat and drink. We are proud that millions of people around the world
consume products containing our ingredients every day.

 

Through our expertise in sweetening, mouthfeel and fibre fortification, we
develop solutions which reduce sugar, calories and fat, add fibre, and provide
texture and stability in categories including beverages, dairy, bakery, soups,
sauces and dressings.

 

We have more than 3,000 employees working in around 60 locations across 30
countries. Tate & Lyle's purpose is Transforming Lives Through the Science
of Food and through our purpose we believe we can successfully grow our
business and have a positive impact on society. We live our purpose in three
ways, by supporting healthy living, building thriving communities and caring
for our planet.

 

Tate & Lyle is listed on the London Stock Exchange under the symbol
TATE.L. American Depositary Receipts trade under TATYY. In the year ended 31
March 2021, Tate & Lyle's revenue from continuing operations totaled £1.2
billion.  For more information, please visit http://www.tateandlyle.com or
follow Tate & Lyle on Twitter or LinkedIn.

 

Tate & Lyle's LEI number is: 2138008K14474WPKZ244

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  FURFIFSRESIVIIF